FDA to Give Staff Bonuses for Speeding Up Drug Reviews

Feb. 26, 2026, 5:16 PM UTC

The US Food and Drug Administration plans to give bonuses to scientific staff for speeding up drug reviews, according to an FDA official familiar with the matter.

The initiative will give staff scientists who perform high quality, efficient reviews bonuses of around a few thousand dollars per quarter, said the person, who didn’t specify as the figures are still being finalized. The agency plans to announce it today at an internal meeting.

The FDA didn’t immediately respond to a request for comment.

The FDA is working hard to meet its drug review deadlines after a year of turmoil. In 2025, ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.